A new enterprise using artificial intelligence to analyze individual cells for immune-related diagnostics and therapies is raising $6 million in seed funds. . . . → Read More: AI Cell Analysis Start-Up Raises $6M Seed Funds
|
|||||
|
       
  |
 3 comments - (Comments are closed)  Finance, New products  biomedical, computer science, engineering, entrepreneurs, equity, investment, life sciences, mathematics, medical device, physical sciences, software, statistics, venture capital 
An advocacy organization for neurodegenerative diseases and medical research foundation are sponsoring formation of a network to collect brain tissue samples. . . . → Read More: Grant Funds Brain Disease Tissue Banks One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, grant, life sciences, mathematics, software, university 
A report by a group advocating for precision medicine notes that the Food and Drug Administration approved 20 new personalized drugs and biologics in 2020. . . . → Read More: 20 Precision Meds Approved by FDA in 2020 Comments are closed Regulations biomedical, biotechnology, FDA, genomics, life sciences, medical device, pharmaceuticals 
An academic-industry team used machine learning to design more effective variations of common benign viruses that deliver gene therapies. . . . → Read More: AI Designs Better Gene Therapy Delivery Viruses 4 comments - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, life sciences, mathematics, pharmaceuticals, physical sciences, university 
Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease. . . . → Read More: Immune Response Shown in Alzheimer’s Vaccine Comments are closed New products biomedical, biotechnology, clinical trials, Europe, licensing, life sciences, pharmaceuticals 
Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, genomics, investment, licensing, life sciences, pharmaceuticals, university 
The Food and Drug Administration granted an emergency authorization for a combination of two synthetic antibodies to treat non-hospitalized Covid-19 infections. . . . → Read More: FDA Clears Covid-19 Dual-Antibody Therapy Comments are closed Regulations biomedical, biotechnology, clinical trials, Covid-19, FDA, life sciences, pharmaceuticals 
A study shows heart rate data captured by an Apple watch can provide an early warning of impending Covid-19 infections, even before a positive test. . . . → Read More: Smartwatch Shown to Offer Early Covid-19 Warning One comment - (Comments are closed) New products biomedical, Covid-19, engineering, life sciences, mathematics, medical device, physical sciences, software, university 
A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, Covid-19, Europe, life sciences, manufacturing, pharmaceuticals, U.K. 
A new study shows an Apple watch can capture data on tremors experienced by people with Parkinson’s disease to help provide more precise care. . . . → Read More: Apple Watch Helps Personalize Parkinson’s Care Comments are closed New products biomedical, clinical trials, engineering, life sciences, mathematics, medical device, physical sciences, software, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||